BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SIM0500 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SIM0500\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06375044-3196@assetmemo.bio
DTSTAMP:20261121T004517Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:SIM0500: Phase 1 readout est. (NCT06375044)
DESCRIPTION:SIM0500\, phase 1\, Multiple Myeloma.\nStudy: Study of SIM0500 
 Alone in Participants With Relapsed or Refractory Multiple Myeloma\nEstima
 ted primary completion: 30 September 2027. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/sim0500#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT06375044
URL:https://assetmemo.bio/drug/sim0500#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
